In vivo assessment of a delayed release formulation of larazotide acetate indicated for celiac disease using a porcine model
Table 1
In vitro dissolution data of 1 mg larazotide acetate of a delayed release formulation in 6 capsules.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
In vitro dissolution data of 1 mg larazotide acetate of a delayed release formulation in 6 capsules.